Alexion beats Q3 estimates; updates guidance

Alexion Pharmaceuticals Inc. (ALXN) reported revenues and earnings for the third quarter of 2018 that came in ahead of expectations. Shares rose

Alexion beats Q3 estimates; updates guidance

Alexion Pharmaceuticals Inc. (ALXN) reported revenues and earnings for the third quarter of 2018 that came in ahead of expectations. Shares rose 3.2% in premarket hours on Wednesday. Total revenues grew 20% to $1.03 billion from the same period last

Viewing Highlight
Loading...
Highlight
Close
Top